SpePharm UK has launched Loramyc (miconazole), a muco-adhesive buccal tablet for the treatment of oropharyngeal candidiasis in immunocompromised patients.

One tablet is applied once daily to the upper gum just above an incisor tooth after brushing teeth for seven to 14 days.

View Loramyc drug record

Futher information: SpePharm

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more